All extracted drugs
Showing 1,141–1,200 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 172 of 876…redict patients who derive clinical benefit from treatment with PDS0101, NHS-IL12, and BA, based on baseline levels and early changes i…
…th autologous tumor. These data support continued evaluation of KSQ-004EX in patients with solid tumors.…
…human TL1A antibody Tulisokibart, anti-human IL-23 p19 antibody Risankizumab, alone or in combination, reduced the weight loss, DAI scores a…
… types, including colorectal tumors. Combinatorial treatment of ICI with anti-CD40 agonist antibody enhanced TIL clonal diversity, …
…s impact tumor microenvironement and our data demonstrates that volrustomig therapeutic approach potentiates anti-tumor immune activity.Abs…
…23–34.Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cel…
…ts with treatment-refractory advanced MSS CRC who received oral Akk probiotic capsules combined with PD-1 inhibitors, evaluating sa…
…g prostatic acid phosphatase (PAP, pTVG-HP) in combination with pembrolizumab in patients with metastatic, castration-resistant prostate canc…
…erence Strati P, Feng L, Tyshevich A, et al. A phase I trial of evorpacept, lenalidomide, and rituximab for patients with B-cell non-hodgk…
…dynamics, immunogenicity, and preliminary antitumor activity of NM32-2668 monotherapy administered every two weeks to patients with ROR1-…